Larvol Delta - Century-Therapeutics-and-Bristol-Myers-Squibb-Enter-into-a-Strategic-Collaboration-to-Develop-iPSCderived-Allogeneic-Cell-Therapies

CD133-specific CAR-T cell therapy - Century Therap

https://www.globenewswire.com/news-release/2022/01/10/2363762/0/en/Century-Therapeutics-and-Bristol-Myers-Squibb-Enter-into-a-Strategic-Collaboration-to-Develop-iPSC-derived-Allogeneic-Cell-Therapies.html

Jan 10, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next